143 related articles for article (PubMed ID: 37781817)
1. Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis.
de Lima Silva EV; Donis KC; Machado FRC; Simão Medeiros L; Aschoff CAM; de Souza CFM; Poswar FO; Saute JAM
J Neuromuscul Dis; 2023; 10(6):1145-1149. PubMed ID: 37781817
[TBL] [Abstract][Full Text] [Related]
2. Long term oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual.
Butala BN; Kang A; Guron J; Brandom BW
J Neuromuscul Dis; 2016 Mar; 3(1):115-119. PubMed ID: 27854207
[TBL] [Abstract][Full Text] [Related]
3. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
[TBL] [Abstract][Full Text] [Related]
4. Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability.
Ibarra Moreno CA; Kraeva N; Zvaritch E; Jungbluth H; Voermans NC; Riazi S
Anesth Analg; 2023 Mar; 136(3):569-577. PubMed ID: 36201369
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome.
Witting N; Laforêt P; Voermans NC; Roux-Buisson N; Bompaire F; Rendu J; Duno M; Feillet F; Kamsteeg EJ; Poulsen NS; Dahlqvist JR; Romero NB; Fauré J; Vissing J; Behin A
Acta Neurol Scand; 2018 May; 137(5):452-461. PubMed ID: 29635721
[TBL] [Abstract][Full Text] [Related]
6. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.
Dlamini N; Voermans NC; Lillis S; Stewart K; Kamsteeg EJ; Drost G; Quinlivan R; Snoeck M; Norwood F; Radunovic A; Straub V; Roberts M; Vrancken AF; van der Pol WL; de Coo RI; Manzur AY; Yau S; Abbs S; King A; Lammens M; Hopkins PM; Mohammed S; Treves S; Muntoni F; Wraige E; Davis MR; van Engelen B; Jungbluth H
Neuromuscul Disord; 2013 Jul; 23(7):540-8. PubMed ID: 23628358
[TBL] [Abstract][Full Text] [Related]
7. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
Voermans NC; Snoeck M; Jungbluth H
Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular symptoms in patients with
van den Bersselaar LR; Jungbluth H; Kruijt N; Kamsteeg EJ; Fernandez-Garcia MA; Treves S; Riazi S; Malagon I; van Eijk LT; van Alfen N; van Engelen BGM; Scheffer GJ; Snoeck MMJ; Voermans NC
Brain Commun; 2022; 4(6):fcac292. PubMed ID: 36751502
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report.
Chiba N; Matsuzaki M; Mawatari T; Mizuochi M; Sakurai A; Kinoshita K
Eur J Med Res; 2021 Feb; 26(1):18. PubMed ID: 33557936
[TBL] [Abstract][Full Text] [Related]
10. The neuromuscular and multisystem features of RYR1-related malignant hyperthermia and rhabdomyolysis: A study protocol.
van den Bersselaar LR; Kruijt N; Scheffer GJ; van Eijk L; Malagon I; Buckens S; Custers JA; Helder L; Greco A; Joosten LA; van Engelen BG; van Alfen N; Riazi S; Treves S; Jungbluth H; Snoeck MM; Voermans NC
Medicine (Baltimore); 2021 Aug; 100(33):e26999. PubMed ID: 34414986
[TBL] [Abstract][Full Text] [Related]
11. The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations.
Knuiman GJ; Küsters B; Eshuis L; Snoeck M; Lammens M; Heytens L; De Ridder W; Baets J; Scalco RS; Quinlivan R; Holton J; Bodi I; Wraige E; Radunovic A; von Landenberg C; Reimann J; Kamsteeg EJ; Sewry C; Jungbluth H; Voermans NC
J Neurol; 2019 Apr; 266(4):876-887. PubMed ID: 30788618
[TBL] [Abstract][Full Text] [Related]
12. The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia.
Noda Y; Mukaida K; Miyoshi H; Nakamura R; Yasuda T; Saeki N; Nishino I; Tsutsumi YM
Anaesth Intensive Care; 2022 Jul; 50(4):312-319. PubMed ID: 35549722
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
Blank JW; Boggs SD
J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
[TBL] [Abstract][Full Text] [Related]
14. Myoplasmic Ca2+ concentration during exertional rhabdomyolysis.
López JR; Rojas B; Gonzalez MA; Terzic A
Lancet; 1995 Feb; 345(8947):424-5. PubMed ID: 7853954
[TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
Kraeva N; Sapa A; Dowling JJ; Riazi S
Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
[TBL] [Abstract][Full Text] [Related]
16. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities.
Lopez RJ; Byrne S; Vukcevic M; Sekulic-Jablanovic M; Xu L; Brink M; Alamelu J; Voermans N; Snoeck M; Clement E; Muntoni F; Zhou H; Radunovic A; Mohammed S; Wraige E; Zorzato F; Treves S; Jungbluth H
Sci Signal; 2016 Jul; 9(435):ra68. PubMed ID: 27382027
[TBL] [Abstract][Full Text] [Related]
17. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.
Carsana A
ScientificWorldJournal; 2013; 2013():531465. PubMed ID: 23476141
[TBL] [Abstract][Full Text] [Related]
18. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility.
Sambuughin N; Capacchione J; Blokhin A; Bayarsaikhan M; Bina S; Muldoon S
Clin Genet; 2009 Dec; 76(6):564-8. PubMed ID: 19807743
[TBL] [Abstract][Full Text] [Related]
19. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.
Zhao F; Li P; Chen SR; Louis CF; Fruen BR
J Biol Chem; 2001 Apr; 276(17):13810-6. PubMed ID: 11278295
[TBL] [Abstract][Full Text] [Related]
20. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]